Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas P Monath

Showing results (111-120 of 136) with videos related to

Pageof 14
Sort By:
Vaccine|June 26, 2017
Clinical development of a recombinant Ebola vaccine in the midst of an unprecedented epidemicBeth-Ann G Coller, Jeffrey Blue, Rituparna Das, et al.
The Lancet. Infectious Diseases|April 9, 2018
Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort studyAngela Huttner, Selidji Todagbe Agnandji, Christophe Combescure, et al.
Vaccine|November 13, 2025
Community interpretation of a consent form and willingness to participate in a Nipah virus vaccine trial in BangladeshNazmun Nahar, Shahana Parveen, Emily S Gurley, et al.
Clinical and Vaccine Immunology : CVI|November 1, 2016
Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus VectorMark R Schleiss, Ursula Berka, Elizabeth Watson, et al.
The American Journal of Tropical Medicine and Hygiene|March 3, 2005
Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (Arilvax and YF-VAX) in healthy infants and children in PeruVivian E Belmusto-Worn, Jose L Sanchez, Karen McCarthy, et al.
Journal of Virology|December 5, 2022
Biographical Feature: Marc S. Collett (23 May 1951-11 June 2022): the Battle against Viral Disease Has Lost a Valiant Warrior, and the World Has Lost a Splendid Human BeingKimberly F Glassman, Joan S Brugge, Anthony F Purchio, et al.
Journal of the American Veterinary Medical Association|July 17, 2008
Executive summary of the AVMA One Health Initiative Task Force reportLonnie J King, Larry R Anderson, Carina G Blackmore, et al.
Plos Pathogens|June 27, 2022
Recombinant vesicular stomatitis vaccine against Nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potentialThomas P Monath, Richard Nichols, Lynda Tussey, et al.
Vaccine|November 6, 2025
Summary of human West Nile virus vaccine meeting, 2024: Investigating barriers to developmentRandall J Nett, Aaron C Brault, Amy J Lambert, et al.
Vaccine|April 7, 2005
Recombination and flavivirus vaccines: a commentaryThomas P Monath, Niranjan Kanesa-Thasan, Farshad Guirakhoo, et al.
Pageof 14

Showing results (111-120 of 136) with videos related to

Sort By:
Pageof 14
Vaccine|June 26, 2017
Clinical development of a recombinant Ebola vaccine in the midst of an unprecedented epidemicBeth-Ann G Coller, Jeffrey Blue, Rituparna Das, et al.
The Lancet. Infectious Diseases|April 9, 2018
Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort studyAngela Huttner, Selidji Todagbe Agnandji, Christophe Combescure, et al.
Vaccine|November 13, 2025
Community interpretation of a consent form and willingness to participate in a Nipah virus vaccine trial in BangladeshNazmun Nahar, Shahana Parveen, Emily S Gurley, et al.
Clinical and Vaccine Immunology : CVI|November 1, 2016
Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus VectorMark R Schleiss, Ursula Berka, Elizabeth Watson, et al.
The American Journal of Tropical Medicine and Hygiene|March 3, 2005
Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (Arilvax and YF-VAX) in healthy infants and children in PeruVivian E Belmusto-Worn, Jose L Sanchez, Karen McCarthy, et al.
Journal of Virology|December 5, 2022
Biographical Feature: Marc S. Collett (23 May 1951-11 June 2022): the Battle against Viral Disease Has Lost a Valiant Warrior, and the World Has Lost a Splendid Human BeingKimberly F Glassman, Joan S Brugge, Anthony F Purchio, et al.
Journal of the American Veterinary Medical Association|July 17, 2008
Executive summary of the AVMA One Health Initiative Task Force reportLonnie J King, Larry R Anderson, Carina G Blackmore, et al.
Plos Pathogens|June 27, 2022
Recombinant vesicular stomatitis vaccine against Nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potentialThomas P Monath, Richard Nichols, Lynda Tussey, et al.
Vaccine|November 6, 2025
Summary of human West Nile virus vaccine meeting, 2024: Investigating barriers to developmentRandall J Nett, Aaron C Brault, Amy J Lambert, et al.
Vaccine|April 7, 2005
Recombination and flavivirus vaccines: a commentaryThomas P Monath, Niranjan Kanesa-Thasan, Farshad Guirakhoo, et al.
Pageof 14